Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old. [electronic resource]
- Vaccine 09 2019
- 5979-5985 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2019.08.028 doi
Australia Cost Savings--economics Cost-Benefit Analysis Female Hospitalization--economics Humans Immunization Programs--economics Influenza Vaccines--economics Influenza, Human--economics Male Middle Aged Vaccination--economics